{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:13:03Z","timestamp":1793459583043,"version":"4.5.0"},"reference-count":347,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>Schizophrenia is a neuropsychiatric illness with no single definitive aetiology, making its treatment difficult. Antipsychotics are not fully effective because they treat psychosis rather than the cognitive or negative symptoms. Antipsychotics fail to alleviate symptoms when patients enter the chronic stage of illness. Topical application of niacin showed diminished skin flush in the majority of patients with schizophrenia compared to the general population who showed flushing. The niacin skin flush test is useful for identifying patients with schizophrenia at their ultra-high-risk stage, and understanding this pathology may introduce an effective treatment. This review aims to understand the pathology behind the diminished skin flush response, while linking it back to neurons and microglia. First, it suggests that there are altered proteins in the GPR109A-COX-prostaglandin pathway, inflammatory imbalance, and kinase signalling pathway, c-Jun N-terminal kinase (JNK), which are associated with diminished flush. Second, genes from the GPR109A-COX-prostaglandin pathway were matched against the 128-loci genome wide association study (GWAS) for schizophrenia using GeneCards, suggesting that G-coupled receptor-109A (GPR109A) may have a genetic mutation, resulting in diminished flush. This review also suggests that there may be increased pro-inflammatory mediators in the GPR109A-COX-prostaglandin pathway, which contributes to the diminished flush pathology. Increased levels of pro-inflammatory markers may induce microglial-activated neuronal death. Lastly, this review explores the role of JNK on pro-inflammatory mediators, proteins in the GPR109A-COX-prostaglandin pathway, microglial activation, and neuronal death. Inhibiting JNK may reverse the changes observed in the diminished flush response, which might make it a good therapeutic target.<\/jats:p>","DOI":"10.3389\/fpsyt.2021.771144","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T15:03:04Z","timestamp":1638370984000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Inflammation and JNK's Role in Niacin-GPR109A Diminished Flushed Effect in Microglial and Neuronal Cells With Relevance to Schizophrenia"],"prefix":"10.3389","volume":"12","author":[{"given":"Sabrina H.","family":"Ansarey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/00048678709160925","article-title":"Did schizophrenia exist before the eighteenth century?","volume":"21","author":"Ellard","year":"1987","journal-title":"Aust N Z J Psychiatry."},{"key":"B2","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/0010-440X(85)90016-1","article-title":"del Carmen R, Lohr JB, Wyatt RJ. Did schizophrenia exist before the eighteenth century?","volume":"26","author":"Jeste","year":"1985","journal-title":"Comprehensive Psychiat."},{"key":"B3","article-title":"The Neuropathology of Schizophrenia. Lawrence Erlbaum Associates.","year":"1994"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1586\/ern.10.93","article-title":"Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders","volume":"10","author":"Larson","year":"2010","journal-title":"Expert Rev Neurother."},{"key":"B5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.31887\/DCNS.2005.7.1\/kdean","article-title":"Environmental risk factors for psychosis","volume":"7","author":"Dean","year":"2005","journal-title":"Dialogues Clin Neurosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.schres.2006.03.014","article-title":"Testing the ultra high risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people","volume":"84","author":"Yung","year":"2006","journal-title":"Schizophr Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/schbul\/22.2.283","article-title":"Monitoring and care of young people at incipient risk of psychosis","volume":"22","author":"Yung","year":"1996","journal-title":"Schizophr Bull."},{"key":"B8","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Vos","year":"2015","journal-title":"Lancet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2147\/NDT.S96649","article-title":"Global economic burden of schizophrenia: a systematic review","volume":"12","author":"Chong","year":"2016","journal-title":"Neuropsychiatr Dis Treat."},{"key":"B10","first-page":"411","article-title":"Mental health in the 21st century","volume":"78","author":"Brundtland","year":"2000","journal-title":"Bull World Health Organ."},{"key":"B11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.plefa.2003.08.008","article-title":"From membrane phospholipid defects to altered neurotransmission: is arachidonic acid a nexus in the pathophysiology of schizophrenia?","volume":"69","author":"Skosnik","year":"2003","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids."},{"key":"B12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1600-0773.1963.tb01730.x","article-title":"Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain","volume":"20","author":"Carlsson","year":"1963","journal-title":"Acta Pharmacol Toxicol."},{"key":"B13","first-page":"492","article-title":"The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs","volume":"160","author":"Van Rossum","year":"1966","journal-title":"Arch Int Pharmacodyn Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"New England journal of medicine."},{"key":"B15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical antipsychotic drugs and the risk of sudden cardiac death","volume":"360","author":"Ray","year":"2009","journal-title":"N Engl J Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/070674370104600308","article-title":"Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities","volume":"46","author":"McIntyre","year":"2001","journal-title":"Can J Psychiatry."},{"key":"B17","article-title":"Niacin Therapy in Psychiatry","author":"Hoffer","year":"1962"},{"key":"B18","first-page":"14","article-title":"Niacin skin flush test: a research tool for studying schizophrenia","volume":"22","author":"Nadalin","year":"2010","journal-title":"Psychiatr Danub."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/0006-3223(86)90321-5","article-title":"Niacin-induced flush as a measure of prostaglandin activity in alcoholics and schizophrenics","volume":"21","author":"Fiedler","year":"1986","journal-title":"Biol Psychiatry."},{"key":"B20","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/0006-3223(91)90202-W","article-title":"Niacin test in schizophrenia and affective illness","volume":"29","author":"Rybakowski","year":"1991","journal-title":"Biol Psychiatry."},{"key":"B21","first-page":"54","article-title":"Schizophrenia: a biochemical disorder?","volume":"32","author":"Horrobin","year":"1980","journal-title":"Biomedicine."},{"key":"B22","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0006-3223(99)00010-4","article-title":"Clinical subtyping reveals significant differences in calcium-dependent phospholipase A2 activity in schizophrenia","volume":"46","author":"Hudson","year":"1999","journal-title":"Biol Psychiatry."},{"key":"B23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.psychres.2005.10.010","article-title":"Niacin skin flushing in schizophrenic and depressed patients and healthy controls","volume":"143","author":"Bosveld-van Haandel","year":"2006","journal-title":"Psychiat Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/schbul\/sbv130","article-title":"Prevalence and Specificity of the Abnormal Niacin Response: A Potential Endophenotype Marker in Schizophrenia","volume":"42","author":"Yao","year":"2015","journal-title":"Schizophrenia Bulletin."},{"key":"B25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0006-3223(96)00112-6","article-title":"The niacin challenge test: Clinical manifestation of altered transmembrane signal transduction in schizophrenia?","volume":"41","author":"Hudson","year":"1997","journal-title":"Biol Psychiatry."},{"key":"B26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0924-977X(97)00089-8","article-title":"Hyperresponsivity to nicotinic acid challenge in generalized social phobia: a pilot study","volume":"8","author":"Bouwer","year":"1998","journal-title":"Eur Neuropsychopharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1172\/JCI27160","article-title":"Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid","volume":"115","author":"Pike","year":"2005","journal-title":"J Clin Invest."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1124\/mol.106.030833","article-title":"Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells","volume":"70","author":"Beny\u00f3","year":"2006","journal-title":"Mol Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"6147","DOI":"10.1073\/pnas.89.13.6147","article-title":"Cytosolic phospholipase A2 is coupled to hormonally regulated release of arachidonic acid","volume":"89","author":"Lin","year":"1992","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0920-9964(99)00031-6","article-title":"Co-distribution of sensory gating and impaired niacin flush response in the parents of schizophrenics","volume":"40","author":"Waldo","year":"1999","journal-title":"Schizophr Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/schbul\/sbl038","article-title":"Familial Aggregation in Skin Flush Response to Niacin Patch Among Schizophrenic Patients and Their Nonpsychotic Relatives","volume":"33","author":"Lin","year":"2006","journal-title":"Schizophr Bull."},{"key":"B32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.psychres.2006.10.002","article-title":"Absent response to niacin skin patch is specific to schizophrenia and independent of smoking","volume":"152","author":"Liu","year":"2007","journal-title":"Psychiatry Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0924-977X(03)00145-7","article-title":"Reduced vasodilatory response to methylnicotinate in schizophrenia as assessed by laser Doppler flowmetry","volume":"14","author":"Ross","year":"2004","journal-title":"Eur Neuropsychopharmacol."},{"key":"B34","first-page":"163","article-title":"Unmedicated schizophrenic patients have a reduced skin flush in response to topical niacin","volume":"43","author":"Shah","year":"2000","journal-title":"Schizophr Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.1172\/JCI23626","article-title":"GPR109A (PUMA-G\/HM74A) mediates nicotinic acid\u2013induced flushing","volume":"115","author":"Beny\u00f3","year":"2005","journal-title":"J Clin Invest."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0006-8993(02)02480-0","article-title":"Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: associated with iNOS and COX-2","volume":"941","author":"Kim","year":"2002","journal-title":"Brain Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/cpt1969104559","article-title":"The relationship between the plasma concentration of free nicotinic acid and some of its pharmacologic effects in man","volume":"10","author":"Svedmyr","year":"1969","journal-title":"Clin Pharmacol Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.2967\/jnumed.109.066647","article-title":"Neuroinflammation in schizophrenia-related psychosis: a PET study","volume":"50","author":"Doorduin","year":"2009","journal-title":"J Nucl Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-244X-11-26","article-title":"Reduced antioxidant defense in early onset first-episode psychosis: a case-control study","volume":"11","author":"Mic\u00f3","year":"2011","journal-title":"BMC Psychiatry."},{"key":"B40","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol Psychiatry."},{"key":"B41","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/schbul\/sbt001","article-title":"Pro-\/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia","volume":"40","author":"Garc\u00eda-Bueno","year":"2014","journal-title":"Schizophr Bull."},{"key":"B42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/schbul\/sbu157","article-title":"Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA","volume":"41","author":"Kenk","year":"2015","journal-title":"Schizophr Bull."},{"key":"B43","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1440-1819.2009.01945.x","article-title":"Cytokines and schizophrenia: Microglia hypothesis of schizophrenia","volume":"63","author":"Monji","year":"2009","journal-title":"Psychiatry Clin Neurosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.pnpbp.2011.12.002","article-title":"Neuroinflammation in schizophrenia especially focused on the role of microglia","volume":"42","author":"Monji","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B45","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","author":"Ripke","year":"2014","journal-title":"Nature."},{"key":"B46","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neubiorev.2013.11.006","article-title":"Inflammation and the two-hit hypothesis of schizophrenia","volume":"38","author":"Feigenson","year":"2014","journal-title":"Neurosci Biobehav Rev."},{"key":"B47","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.schres.2014.04.041","article-title":"Neuroinflammation and white matter pathology in schizophrenia: systematic review","volume":"161","author":"Najjar","year":"2015","journal-title":"Schizophr Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1046\/j.1468-1331.1999.640437.x","article-title":"High levels of IL-10 secreting cells are present in blood in cerebrovascular diseases","volume":"6","author":"Pelidou","year":"1999","journal-title":"Eur J Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1176\/appi.ajp.157.5.683","article-title":"Remick, M. D. Cytokines and the brain: implications for clinical psychiatry","volume":"157","author":"Kronfol","year":"2000","journal-title":"Am J Psychiatry."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1161\/CIRCULATIONAHA.105.593046","article-title":"Role of T lymphocytes and interferon-in ischemic stroke","volume":"113","author":"Yilmaz","year":"2006","journal-title":"Circulation."},{"key":"B51","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuron.2009.09.002","article-title":"Cytokines and CNS development","volume":"64","author":"Deverman","year":"2009","journal-title":"Neuron."},{"key":"B52","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review","volume":"63","author":"Potvin","year":"2008","journal-title":"Biol Psychiatry."},{"key":"B53","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1007\/PL00014187","article-title":"The role of immune function in schizophrenia: an overview","volume":"249","author":"M\u00fcller","year":"1999","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/mp.2009.52","article-title":"Activation of brain interleukin-1beta in schizophrenia","volume":"14","author":"S\u00f6derlund","year":"2009","journal-title":"Mol Psychiatry."},{"key":"B55","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","article-title":"Cytokines sing the blues: inflammation and the pathogenesis of depression","volume":"27","author":"Raison","year":"2006","journal-title":"Trends Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol Psychiatry"},{"key":"B57","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/schbul\/sbx035","article-title":"Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression","volume":"44","author":"Wang","year":"2018","journal-title":"Schizophr Bull."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/jamapsychiatry.2014.1332","article-title":"Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study","volume":"71","author":"Khandaker","year":"2014","journal-title":"JAMA psychiatry."},{"key":"B59","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.4049\/jimmunol.137.10.3295","article-title":"Increased superoxide anion release from human endothelial cells in response to cytokines","volume":"137","author":"Matsubara","year":"1986","journal-title":"J Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1042\/bj2750241","article-title":"Identification of a superoxide-generating NADPH oxidase system in human fibroblasts","volume":"275","author":"Meier","year":"1991","journal-title":"Biochemical Journal."},{"key":"B61","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1165\/ajrcmb.20.5.3452","article-title":"Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-\u03ba b: requirement of ras\/mitogen-activated protein kinases in the activation of Nf-\u03ba B by oxidants","volume":"20","author":"Janssen-Heininger","year":"1999","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/sj.onc.1202094","article-title":"TNF-\u03b1 activates at least two apoptotic signaling cascades","volume":"17","author":"Sidoti-de Fraisse","year":"1998","journal-title":"Oncogene"},{"key":"B63","doi-asserted-by":"publisher","first-page":"15746","DOI":"10.1074\/jbc.M110.103259","article-title":"Oxidants positively or negatively regulate nuclear factor kappaB in a context-dependent manner","volume":"285","author":"Loukili","year":"2010","journal-title":"J Biol Chem."},{"key":"B64","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.eurpsy.2017.09.007","article-title":"Regulation of inflammatory pathways in schizophrenia: A comparative study with bipolar disorder and healthy controls","volume":"47","author":"Garc\u00eda-\u00c1lvarez","year":"2018","journal-title":"Eur Psychiatry."},{"key":"B65","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.1046\/j.1460-9568.2000.00229.x","article-title":"Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo","volume":"12","author":"Do","year":"2000","journal-title":"Eur J Neurosci"},{"key":"B66","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1155\/2006\/248387","article-title":"Altered glutathione redox state in schizophrenia","volume":"22","author":"Yao","year":"2006","journal-title":"Disease Markers"},{"key":"B67","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1017\/S1461145710000805","article-title":"Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders","volume":"14","author":"Gawryluk","year":"2011","journal-title":"Int J Neuropsychopharmacol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1515\/CCLM.2000.201","article-title":"Erythrocyte superoxide dismutase and glutathione peroxidase activities, and malondialdehyde and reduced glutathione levels in schizophrenic patients","volume":"38","author":"Altuntas","year":"2000","journal-title":"Clin Chem Lab Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.brainres.2008.03.092","article-title":"Disease-specific alterations in glutamatergic neurotransmission on inhibitory interneurons in the prefrontal cortex in schizophrenia","volume":"1218","author":"Woo","year":"2008","journal-title":"Brain Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/j.1471-4159.2007.04487.x","article-title":"Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation","volume":"101","author":"Barger","year":"2007","journal-title":"J Neurochem."},{"key":"B71","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0165-0173(97)00045-3","article-title":"Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death","volume":"25","author":"Bains","year":"1997","journal-title":"Brain Res Rev."},{"key":"B72","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0920-9964(02)00405-X","article-title":"Dopamine-induced oxidative stress in neurons with glutathione deficit: implication for schizophrenia","volume":"62","author":"Grima","year":"2003","journal-title":"Schizophr Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s005990050063","article-title":"An update on the role of free radicals and antioxidant defense in human disease","volume":"29","author":"Vendemiale","year":"1999","journal-title":"Int J Clin Lab Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.biopsych.2013.03.018","article-title":"Meta-Analysis of Oxidative Stress in Schizophrenia","volume":"74","author":"Flatow","year":"2013","journal-title":"Biol Psychiatry."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1111\/j.1471-4159.1992.tb10990.x","article-title":"Reactive oxygen species and the central nervous system","volume":"59","author":"Halliwell","year":"1992","journal-title":"J Neurochem."},{"key":"B76","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1471-4159.2011.07572.x","article-title":"Inhibition of NADPH oxidase promotes alternative and anti-inflammatory microglial activation during neuroinflammation","volume":"120","author":"Choi","year":"2012","journal-title":"J Neurochem."},{"key":"B77","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.neuint.2012.12.016","article-title":"Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson's disease","volume":"62","author":"Taylor","year":"2013","journal-title":"Neurochem Int."},{"key":"B78","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.intimp.2012.09.004","article-title":"Protosappanin A inhibits oxidative and nitrative stress via interfering the interaction of transmembrane protein CD14 with Toll-like receptor-4 in lipopolysaccharide-induced BV-2 microglia","volume":"14","author":"Zeng","year":"2012","journal-title":"Int Immunopharmacol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"17151","DOI":"10.1073\/pnas.0806682105","article-title":"Microglial activation and TNF\u03b1 production mediate altered CNS excitability following peripheral inflammation","volume":"105","author":"Riazi","year":"2008","journal-title":"Proc Nat Acad Sci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/01.WCB.0000061881.75234.5E","article-title":"Macrophages and microglia in central nervous system injury: are they helpful or harmful?","volume":"23","author":"Schwartz","year":"2003","journal-title":"J Cereb Blood Flow Metab."},{"key":"B81","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0165-5728(93)90027-V","article-title":"Murine tumor necrosis factor alpha is transported from blood to brain in the mouse","volume":"47","author":"Gutierrez","year":"1993","journal-title":"J Neuroimmunol."},{"key":"B82","first-page":"988","article-title":"Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism","volume":"259","author":"Banks","year":"1991","journal-title":"J Pharmacol Exp Ther."},{"key":"B83","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.3389\/fimmu.2018.02877","article-title":"Circumventricular Organs and Parasite Neurotropism: Neglected Gates to the Brain?","volume":"9","author":"Bentivoglio","year":"2018","journal-title":"Front Immunol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.iac.2009.02.001","article-title":"The blood\u2013brain barrier in psychoneuroimmunology","volume":"29","author":"Banks","year":"2009","journal-title":"Immunol Allergy Clin North Am."},{"key":"B85","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jconrel.2018.08.035","article-title":"Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease","volume":"287","author":"Qu","year":"2018","journal-title":"J Control Release."},{"key":"B86","doi-asserted-by":"publisher","first-page":"e1001874","DOI":"10.1371\/journal.pbio.1001874","article-title":"Extracellular Vesicle-Mediated Transfer of Genetic Information between the Hematopoietic System and the Brain in Response to Inflammation","volume":"12","author":"Ridder","year":"2014","journal-title":"PLoS Biol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1038\/nprot.2012.131","article-title":"Exosome-mediated delivery of siRNA in vitro and in vivo","volume":"7","author":"El-Andaloussi","year":"2012","journal-title":"Nat Protoc."},{"key":"B88","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1600-0854.2010.01041.x","article-title":"Cellular internalization of exosomes occurs through phagocytosis","volume":"11","author":"Feng","year":"2010","journal-title":"Traffic."},{"key":"B89","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1017\/S1461145707008401","article-title":"Oxidative stress in psychiatric disorders: evidence base and therapeutic implications","volume":"11","author":"Ng","year":"2008","journal-title":"Int J Neuropsychopharmacol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.jpsychires.2012.03.019","article-title":"Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity","volume":"46","author":"Pedrini","year":"2012","journal-title":"J Psychiatr Res."},{"key":"B91","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-1-4939-0440-2_2","article-title":"Oxidative Stress in Schizophrenia.","volume-title":"Studies on Psychiatric Disorders","author":"Dietrich-Muszalska","year":"2015"},{"key":"B92","first-page":"1137","article-title":"Biological role of the superoxide anion radical and of superoxyde-dismutase in cellular metabolism","volume":"170","author":"Michelson","year":"1976","journal-title":"C R Seances Soc Biol Fil."},{"key":"B93","doi-asserted-by":"publisher","first-page":"256","DOI":"10.14336\/AD.2014.0500256","article-title":"Accelerated aging in schizophrenia patients: the potential role of oxidative stress","volume":"5","author":"Okusaga","year":"2014","journal-title":"Aging Dis."},{"key":"B94","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0165-1781(03)00222-1","article-title":"Overproduction of neutrophil radical oxygen species correlates with negative symptoms in schizophrenic patients: parallel studies on neutrophil chemotaxis, superoxide production and bactericidal activity","volume":"121","author":"Sirota","year":"2003","journal-title":"Psychiatry Res."},{"key":"B95","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.conb.2009.05.001","article-title":"Redox dysregulation, neurodevelopment, and schizophrenia","volume":"19","author":"Do","year":"2009","journal-title":"Curr Opin Neurobiol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/neuro.08.014.2009","article-title":"Early-life programming of later-life brain and behavior: a critical role for the immune system","volume":"3","author":"Bilbo","year":"2009","journal-title":"Front Behav Neurosci"},{"key":"B97","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.biopsych.2008.04.025","article-title":"Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C] PK11195 positron emission tomography study","volume":"64","author":"Van Berckel","year":"2008","journal-title":"Biol Psychiatry."},{"key":"B98","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1176\/appi.ajp.2015.14101358","article-title":"Microglial activity in people at ultra high risk of psychosis and in schizophrenia: an [11C] PBR28 PET brain imaging study","volume":"173","author":"Bloomfield","year":"2016","journal-title":"Am J Psychiatry."},{"key":"B99","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1038\/tp.2012.116","article-title":"Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies","volume":"2","author":"Vita","year":"2012","journal-title":"Transl Psychiatry."},{"key":"B100","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1136\/jnnp.65.4.446","article-title":"Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia","volume":"65","author":"Garey","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1001\/jamapsychiatry.2014.1582","article-title":"Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder","volume":"71","author":"Konopaske","year":"2014","journal-title":"JAMA Psychiat."},{"key":"B102","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.biopsych.2014.05.023","article-title":"Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk","volume":"77","author":"Cannon","year":"2015","journal-title":"Biol Psychiatry."},{"key":"B103","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41380-018-0041-5","article-title":"Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures","volume":"24","author":"Osimo","year":"2019","journal-title":"Mol Psychiatry."},{"key":"B104","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3389\/fnsys.2015.00190","article-title":"Hippocampal-prefrontal interactions in cognition, behavior and psychiatric disease","volume":"9","author":"Sigurdsson","year":"2016","journal-title":"Front Syst Neurosci"},{"key":"B105","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nm.2266","article-title":"Weiner HL. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C\/EBP-\u03b1-PU1 pathway","volume":"17","author":"Ponomarev","year":"2011","journal-title":"Nat Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1126\/science.290.5497.1768","article-title":"Down-regulation of the macrophage lineage through interaction with OX2 (CD200)","volume":"290","author":"Hoek","year":"2000","journal-title":"Science."},{"key":"B107","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2174\/1389203711314010004","article-title":"Neuron-microglia interaction in neuroinflammation","volume":"14","author":"Akio","year":"2013","journal-title":"Curr Protein Pept Sci."},{"key":"B108","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1523\/JNEUROSCI.4363-08.2009","article-title":"Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals","volume":"29","author":"Wake","year":"2009","journal-title":"J Neurosci."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.devcel.2012.10.027","article-title":"Du X-f, Liu C-s, Wen Z-l, Du J-l. Reciprocal regulation between resting microglial dynamics and neuronal activity in vivo developmental","volume":"23","author":"Li","year":"2012","journal-title":"Cell."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1084\/jem.20150237","article-title":"members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes","volume":"214","author":"Freeman","year":"2017","journal-title":"J Exp Med."},{"key":"B111","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1523\/JNEUROSCI.4486-04.2005","article-title":"Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha","volume":"25","author":"Stellwagen","year":"2005","journal-title":"J Neurosci."},{"key":"B112","doi-asserted-by":"publisher","first-page":"8430123","DOI":"10.1155\/2018\/8430123","article-title":"Tumor necrosis factor and interleukin-1\u03b2 modulate synaptic plasticity during neuroinflammation","volume":"2018","author":"Rizzo","year":"2018","journal-title":"Neural Plasticity"},{"key":"B113","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/jnc.12263","article-title":"IL-1\u03b2 and TNF-\u03b1 induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase","volume":"125","author":"Ye","year":"2013","journal-title":"J Neurochem."},{"key":"B114","doi-asserted-by":"publisher","first-page":"E197","DOI":"10.1073\/pnas.1111098109","article-title":"Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission","volume":"109","author":"Pascual","year":"2012","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B115","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/sj.cr.7290257","article-title":"Activation and signaling of the p38 MAP kinase pathway","volume":"15","author":"Zarubin","year":"2005","journal-title":"Cell Res."},{"key":"B116","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/cells8020194","article-title":"Anti-inflammatory effect of sulforaphane on LPS-Activated Microglia Potentially through JNK\/AP-1\/NF-\u03baB Inhibition and Nrf2\/HO-1 Activation","volume":"8","author":"Subedi","year":"2019","journal-title":"Cells."},{"key":"B117","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41537-017-0032-6","article-title":"Abnormalities of signal transduction networks in chronic schizophrenia","volume":"3","author":"McGuire","year":"2017","journal-title":"NPJ Schizophrenia."},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00028.2011","article-title":"Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update","author":"Kyriakis","year":"2012","journal-title":"Physiol Rev."},{"key":"B119","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/bies.950180708","article-title":"Protein kinase cascades activated by stress and inflammatory cytokines","volume":"18","author":"Kyriakis","year":"1996","journal-title":"Bioessays."},{"key":"B120","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0955-0674(98)80143-9","article-title":"Signal transduction by the c-Jun N-terminal kinase (JNK) \u2014 from inflammation to development","volume":"10","author":"Ip","year":"1998","journal-title":"Curr Opin Cell Biol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"9113","DOI":"10.1074\/jbc.272.14.9113","article-title":"Discordant activation of stress-activated protein kinases or c-Jun NH2-terminal protein kinases in tissues of heat-stressed mice","volume":"272","author":"Hu","year":"1997","journal-title":"J Biol Chem."},{"key":"B122","doi-asserted-by":"publisher","first-page":"7602","DOI":"10.1523\/JNEUROSCI.20-20-07602.2000","article-title":"Dual roles for c-Jun N-terminal kinase in developmental and stress responses in cerebellar granule neurons","volume":"20","author":"Coffey","year":"2000","journal-title":"J Neurosci."},{"key":"B123","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1002\/j.1460-2075.1996.tb00636.x","article-title":"Selective interaction of JNK protein kinase isoforms with transcription factors","volume":"15","author":"Gupta","year":"1996","journal-title":"EMBO J."},{"key":"B124","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0169-328X(98)00166-1","article-title":"Differential expression of SAPK isoforms in the rat brain. An in situ hybridisation study in the adult rat brain and during post-natal development","volume":"60","author":"Carboni","year":"1998","journal-title":"Mol Brain Res."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1002\/j.1460-2075.1995.tb07167.x","article-title":"ATF-2 contains a phosphorylation-dependent transcriptional activation domain","volume":"14","author":"Livingstone","year":"1995","journal-title":"EMBO J."},{"key":"B126","doi-asserted-by":"publisher","first-page":"5424","DOI":"10.1210\/en.2006-0643","article-title":"Interleukin-1beta signals through a c-Jun N-terminal kinase-dependent inducible nitric oxide synthase and nitric oxide production pathway in Sertoli epithelial cells","volume":"147","author":"Ishikawa","year":"2006","journal-title":"Endocrinology."},{"key":"B127","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1101\/gad.1223004","article-title":"JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species.","volume":"18","author":"Ventura","year":"2004","journal-title":"Genes Dev."},{"key":"B128","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1016\/j.febslet.2014.05.046","article-title":"Tumour necrosis factor alpha-induced neuronal loss is mediated by microglial phagocytosis","volume":"588","author":"Neniskyte","year":"2014","journal-title":"FEBS Lett."},{"key":"B129","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.phymed.2016.05.002","article-title":"Anti-neuroinflammatory and neuroprotective effects of the Lindera neesiana fruit in vitro","volume":"23","author":"Subedi","year":"2016","journal-title":"Phytomedicine."},{"key":"B130","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/glia.10314","article-title":"Activated glia induce neuron death via MAP kinase signaling pathways involving JNK and p38","volume":"45","author":"Xie","year":"2004","journal-title":"Glia."},{"key":"B131","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.plefa.2006.02.002","article-title":"Niacin skin-flush response and electrodermal activity in patients with schizophrenia and healthy controls","volume":"74","author":"Nilsson","year":"2006","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids."},{"key":"B132","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1038\/ncomms4944","article-title":"The \u03b2-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages","volume":"5","author":"Rahman","year":"2014","journal-title":"Nat Commun."},{"key":"B133","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/CCM.0b013e3181feeae4","article-title":"Niacin attenuates lung inflammation and improves survival during sepsis by downregulating the nuclear factor-\u03baB pathway","volume":"39","author":"Kwon","year":"2011","journal-title":"Crit Care Med."},{"key":"B134","doi-asserted-by":"publisher","first-page":"F106","DOI":"10.1152\/ajprenal.00126.2009","article-title":"Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failure","volume":"297","author":"Cho","year":"2009","journal-title":"Am J Physiol Renal Physiol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1741-7015-3-11","article-title":"The influence of long chain polyunsaturate supplementation on docosahexaenoic acid and arachidonic acid in baboon neonate central nervous system","volume":"3","author":"Diau","year":"2005","journal-title":"BMC Med."},{"key":"B136","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0305-0491(96)00019-3","article-title":"Polyunsaturated fatty acids in neutral lipids and phospholipids of some freshwater insects","volume":"114","author":"Ghioni","year":"1996","journal-title":"Comparative Biochem Physiol Part B Biochem Mol Biol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"23203","DOI":"10.1074\/jbc.M500985200","article-title":"Neuronal expression and neuritogenic action of group X secreted phospholipase A2","volume":"280","author":"Masuda","year":"2005","journal-title":"J Biol Chem."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1111\/j.1471-4159.2007.04570.x","article-title":"Lysophosphatidylcholine potentiates Ca2+ influx, pore formation and p44\/42 MAP kinase phosphorylation mediated by P2X7 receptor activation in mouse microglial cells","volume":"102","author":"Takenouchi","year":"2007","journal-title":"J Neurochem."},{"key":"B139","doi-asserted-by":"crossref","DOI":"10.1093\/acprof:oso\/9780198717478.001.0001","volume-title":"Free Radicals in Biology and Medicine","author":"Halliwell","year":"2015"},{"key":"B140","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1749-6632.1993.tb32277.x","article-title":"The activation and activity control of AP-1 (fos\/jun)","volume":"684","author":"Radler-Pohl","year":"1993","journal-title":"Ann N Y Acad Sci."},{"key":"B141","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1172\/JCI11914","article-title":"Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer","volume":"107","author":"Yamamoto","year":"2001","journal-title":"J Clin Invest."},{"key":"B142","doi-asserted-by":"publisher","first-page":"6003","DOI":"10.1074\/jbc.274.9.6003","article-title":"JunB forms the majority of the AP-1 complex and is a target for redox regulation by receptor tyrosine kinase and G protein-coupled receptor agonists in smooth muscle cells*","volume":"274","author":"Rao","year":"1999","journal-title":"J Biol Chem."},{"key":"B143","doi-asserted-by":"publisher","first-page":"27760","DOI":"10.1074\/jbc.271.44.27760","article-title":"Role of hydroperoxyeicosatetraenoic acids in oxidative stress-induced activating protein 1 (AP-1) activity","volume":"271","author":"Rao","year":"1996","journal-title":"J Biol Chem."},{"key":"B144","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0098-2997(03)00023-2","article-title":"4-Hydroxynonenal as a bioactive marker of pathophysiological processes","volume":"24","author":"Zarkovic","year":"2003","journal-title":"Mol Aspects Med."},{"key":"B145","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0006-8993(00)02270-8","article-title":"Cyclopentenone prostaglandin 15-deoxy-\u039412,14-prostaglandin J2 acts as a general inhibitor of inflammatory responses in activated BV-2 microglial cells","volume":"867","author":"Koppal","year":"2000","journal-title":"Brain Res."},{"key":"B146","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/47520","article-title":"Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of I\u03baB kinase","volume":"403","author":"Rossi","year":"2000","journal-title":"Nature."},{"key":"B147","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0165-5728(98)00267-7","article-title":"Proteasome blockers inhibit TNF-\u03b1 release by lipopolysaccharide stimulated macrophages and microglia: implications for HIV-1 dementia","volume":"95","author":"Fine","year":"1999","journal-title":"J Neuroimmunol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-\u03b3 is a negative regulator of macrophage activation","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature."},{"key":"B149","doi-asserted-by":"publisher","first-page":"4668","DOI":"10.1073\/pnas.96.8.4668","article-title":"Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-\u039412, 14-prostaglandin J2","volume":"96","author":"Petrova","year":"1999","journal-title":"Proc Nat Acad Sci."},{"key":"B150","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1046\/j.1460-9568.2000.00110.x","article-title":"Role of the peroxisome proliferator-activated receptor-\u03b3 (PPAR-\u03b3) and its natural ligand 15-deoxy-\u039412, 14-prostaglandin J2 in the regulation of microglial functions","volume":"12","author":"Bernardo","year":"2000","journal-title":"Eur J Neurosci."},{"key":"B151","doi-asserted-by":"publisher","first-page":"6862","DOI":"10.1523\/JNEUROSCI.20-18-06862.2000","article-title":"Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo","volume":"20","author":"Heneka","year":"2000","journal-title":"J Neurosci."},{"key":"B152","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.2741\/2802","article-title":"Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists","volume":"13","author":"Kapadia","year":"2008","journal-title":"Front Biosci."},{"key":"B153","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0197-4580(01)00296-2","article-title":"Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease","volume":"22","author":"Landreth","year":"2001","journal-title":"Neurobiol Aging."},{"key":"B154","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0171-2985(97)80025-3","article-title":"Regulation of NF-kappa B activation by MAP kinase cascades","volume":"198","author":"Schulze-Osthoff","year":"1997","journal-title":"Immunobiology."},{"key":"B155","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/molehr\/6.6.561","article-title":"NF-\u03baB and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH)","volume":"6","author":"Allport","year":"2000","journal-title":"Mol Hum Reprod."},{"key":"B156","doi-asserted-by":"publisher","first-page":"7367","DOI":"10.1073\/pnas.112212599","article-title":"15-Deoxy-Delta(12,14)-prostaglandin J(2): the endogenous electrophile that induces neuronal apoptosis","volume":"99","author":"Kondo","year":"2002","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B157","first-page":"181","article-title":"Paradigm for gene regulation: inflammation, NF-\u03baB and PPAR","author":"Vanden Berghe","year":"2003"},{"key":"B158","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00011-019-01231-1","article-title":"Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors","volume":"68","author":"Korbecki","year":"2019","journal-title":"Inflammat Res."},{"key":"B159","doi-asserted-by":"publisher","first-page":"22605","DOI":"10.1074\/jbc.M109.087213","article-title":"Internalization of the human nicotinic acid receptor GPR109A is regulated by G(i), GRK2, and arrestin3","volume":"285","author":"Li","year":"2010","journal-title":"J Biol Chem."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1126\/science.287.5455.1034","article-title":"Localization of the G protein betagamma complex in living cells during chemotaxis","volume":"287","author":"Jin","year":"2000","journal-title":"Science."},{"key":"B161","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1006\/excr.1999.4687","article-title":"New insights into the control of MAP kinase pathways","volume":"253","author":"English","year":"1999","journal-title":"Exp Cell Res."},{"key":"B162","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/ni.2258","article-title":"Bidirectional regulation of neutrophil migration by mitogen-activated protein kinases","volume":"13","author":"Liu","year":"2012","journal-title":"Nat Immunol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"857","DOI":"10.4049\/jimmunol.1390044","article-title":"TLR4 Signaling augments monocyte chemotaxis by regulating G protein\u2013coupled receptor kinase 2 translocation","volume":"191","author":"Liu","year":"2013","journal-title":"J Immunol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1126\/science.290.5496.1574","article-title":"\u03b2-arrestin 2: A receptor-regulated MAPK scaffold for the activation of JNK3","volume":"290","author":"McDonald","year":"2000","journal-title":"Science."},{"key":"B165","doi-asserted-by":"publisher","first-page":"7450","DOI":"10.1074\/jbc.M115.687129","article-title":"Ubiquitin-specific protease 20 regulates the reciprocal functions of \u03b2-arrestin2 in toll-like receptor 4-promoted nuclear factor \u03baB (NF\u03baB) activation","volume":"291","author":"Jean-Charles","year":"2016","journal-title":"J Biol Chem."},{"key":"B166","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/glia.20886","article-title":"Regulatory role of cytosolic phospholipase A2alpha in NADPH oxidase activity and in inducible nitric oxide synthase induction by aggregated Abeta1-42 in microglia","volume":"57","author":"Szaingurten-Solodkin","year":"2009","journal-title":"Glia."},{"key":"B167","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1083\/jcb.200211056","article-title":"Unique targeting of cytosolic phospholipase A2 to plasma membranes mediated by the NADPH oxidase in phagocytes","volume":"162","author":"Shmelzer","year":"2003","journal-title":"J Cell Biol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1073\/pnas.94.8.3771","article-title":"Arachidonic acid activates c-jun N-terminal kinase through NADPH oxidase in rabbit proximal tubular epithelial cells","volume":"94","author":"Cui","year":"1997","journal-title":"Proc Nat Acad Sci."},{"key":"B169","doi-asserted-by":"publisher","first-page":"25934","DOI":"10.1016\/S0021-9258(18)35698-9","article-title":"Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide","volume":"267","author":"Lee","year":"1992","journal-title":"J Biol Chem."},{"key":"B170","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1073\/pnas.94.7.2869","article-title":"Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase\/stress-activated protein kinase activation","volume":"94","author":"Schwenger","year":"1997","journal-title":"Proc Nat Acad Sci."},{"key":"B171","doi-asserted-by":"publisher","first-page":"22903","DOI":"10.1074\/jbc.274.33.22903","article-title":"Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition","volume":"274","author":"Marnett","year":"1999","journal-title":"J Biol Chem."},{"key":"B172","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.neubiorev.2008.04.001","article-title":"Stress as a neuroinflammatory condition in brain: damaging and protective mechanisms","volume":"32","author":"Garc\u00eda-Bueno","year":"2008","journal-title":"Neurosci Biobehav Rev."},{"key":"B173","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.3389\/fmicb.2018.02447","article-title":"PGE2 Augments Inflammasome Activation and M1 Polarization in Macrophages Infected With Salmonella Typhimurium and Yersinia enterocolitica","volume":"9","author":"Sheppe","year":"2018","journal-title":"Front Microbiol"},{"key":"B174","doi-asserted-by":"publisher","first-page":"361","DOI":"10.4049\/jimmunol.164.1.361","article-title":"Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis","volume":"164","author":"Stolina","year":"2000","journal-title":"J Immunol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/cne.20052","article-title":"Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: Relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli","volume":"472","author":"Konsman","year":"2004","journal-title":"J Comparat Neurol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S0741-5214(97)70210-6","article-title":"Prostaglandin E2 synthesis and cyclooxygenase expression in abdominal aortic aneurysms","volume":"25","author":"Holmes","year":"1997","journal-title":"J Vasc Surg."},{"key":"B177","doi-asserted-by":"publisher","first-page":"49954","DOI":"10.1074\/jbc.M307964200","article-title":"Cyclooxygenase-2 induction by bradykinin in human pulmonary artery smooth muscle cells is mediated by the cyclic AMP response element through a novel autocrine loop involving endogenous prostaglandin E2, E-prostanoid 2 (EP2), and EP4 receptors","volume":"278","author":"Bradbury","year":"2003","journal-title":"J Biol Chem."},{"key":"B178","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1042\/BJ20111052","article-title":"Involvement of PGE2 and the cAMP signalling pathway in the up-regulation of COX-2 and mPGES-1 expression in LPS-activated macrophages","volume":"443","author":"D\u00edaz-Mu\u00f1oz","year":"2012","journal-title":"Biochem J."},{"key":"B179","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0090-6980(95)00168-9","article-title":"Role of prostaglandin H synthase-2 in prostaglandin E2 formation in rat carrageenin-induced pleurisy","volume":"51","author":"Harada","year":"1996","journal-title":"Prostaglandins."},{"key":"B180","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1074\/jbc.274.4.2234","article-title":"Activation of stress signaling pathways by the end product of lipid peroxidation. 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production.","volume":"274","author":"Uchida","year":"1999","journal-title":"J Biol Chem."},{"key":"B181","doi-asserted-by":"publisher","first-page":"13422","DOI":"10.1074\/jbc.271.23.13422","article-title":"Role of oxidants and antioxidants in the induction of AP-1, NF-kappaB, and glutathione S-transferase gene expression","volume":"271","author":"Pinkus","year":"1996","journal-title":"J Biol Chem."},{"key":"B182","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s001090050063","article-title":"Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways","volume":"74","author":"Whitmarsh","year":"1996","journal-title":"J Mol Med (Berl)."},{"key":"B183","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0920-9964(94)90043-4","article-title":"The membrane hypothesis of schizophrenia","volume":"13","author":"Horrobin","year":"1994","journal-title":"Schizophr Res."},{"key":"B184","first-page":"759","article-title":"Phospholipid and prostaglandin hypotheses of schizophrenia","volume-title":"Psychopharmacology: The third generation of progress","author":"Rotrosen","year":"1987"},{"key":"B185","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.1021\/pr300459d","article-title":"Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-na\u00efve schizophrenia patients after treatment with risperidone","volume":"11","author":"Cai HL Li","year":"2012","journal-title":"J Proteome Res."},{"key":"B186","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/0006-3223(91)90239-I","article-title":"Increased platelet membrane lysophosphatidylcholine in schizophrenia","volume":"30","author":"Pangerl","year":"1991","journal-title":"Biol Psychiatry."},{"key":"B187","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gm300","article-title":"Phospholipids and insulin resistance in psychosis: a lipidomics study of twin pairs discordant for schizophrenia","volume":"4","author":"Ore\u0161i\u010d","year":"2012","journal-title":"Genome Med."},{"key":"B188","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/JCP.0b013e318248b7bb","article-title":"Eicosapentaenoic acid interventions in schizophrenia: meta-analysis of randomized, placebo-controlled studies","volume":"32","author":"Fusar-Poli","year":"2012","journal-title":"J Clin Psychopharmacol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0006-8993(02)03300-0","article-title":"Dietary long chain PUFAs differentially affect hippocampal muscarinic 1 and serotonergic 1A receptors in experimental cerebral hypoperfusion","volume":"954","author":"Farkas","year":"2002","journal-title":"Brain Res."},{"key":"B190","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.neuroimage.2010.05.009","article-title":"Phospholipase A2 activity is associated with structural brain changes in schizophrenia","volume":"52","author":"Smesny","year":"2010","journal-title":"Neuroimage."},{"key":"B191","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.schres.2010.07.026","article-title":"Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness","volume":"123","author":"Preti","year":"2010","journal-title":"Schizophr Res."},{"key":"B192","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.arcmed.2011.06.010","article-title":"Supplementation of n3 long-chain polyunsaturated fatty acid synergistically decreases insulin resistance with weight loss of obese prepubertal and pubertal children","volume":"42","author":"L\u00f3pez-Alarc\u00f3n","year":"2011","journal-title":"Arch Med Res."},{"key":"B193","doi-asserted-by":"publisher","first-page":"5944","DOI":"10.1021\/cr200084z","article-title":"Free radical lipid peroxidation: mechanisms and analysis","volume":"111","author":"Yin","year":"2011","journal-title":"Chem Rev."},{"key":"B194","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0891-5849(91)90192-6","article-title":"Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes","volume":"11","author":"Esterbauer","year":"1991","journal-title":"Free Radic Biol Med."},{"key":"B195","doi-asserted-by":"publisher","first-page":"360438","DOI":"10.1155\/2014\/360438","article-title":"Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal","volume":"2014","author":"Ayala","year":"2014","journal-title":"Oxid Med Cell Longev."},{"key":"B196","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1046\/j.1471-4159.1997.68010255.x","article-title":"A Role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid \u03b2-peptide","volume":"68","author":"Mark","year":"1997","journal-title":"J Neurochem."},{"key":"B197","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1046\/j.1471-4159.2000.0740159.x","article-title":"The lipid peroxidation product 4-hydroxy-2,3-nonenal increases AP-1-binding activity through caspase activation in neurons","volume":"74","author":"Camandola","year":"2000","journal-title":"J Neurochem."},{"key":"B198","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0891-5849(89)90010-5","article-title":"On the detection of lipid hydroperoxides in biological samples","volume":"7","author":"Pryor","year":"1989","journal-title":"Free Radic Biol Med."},{"key":"B199","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj2190001","article-title":"Oxygen toxicity, oxygen radicals, transition metals and disease","volume":"219","author":"Halliwell","year":"1984","journal-title":"Biochem J."},{"key":"B200","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.pnpbp.2006.09.012","article-title":"Assessment of malondialdehyde levels in schizophrenia: a meta-analysis and some methodological considerations","volume":"31","author":"Grignon","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol."},{"key":"B201","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/15622970701361263","article-title":"Isoprostenes as indicators of oxidative stress in schizophrenia","volume":"10","author":"Dietrich-Muszalska","year":"2009","journal-title":"World J Biol Psychiatry."},{"key":"B202","doi-asserted-by":"publisher","first-page":"2325162","DOI":"10.1155\/2016\/2325162","article-title":"Possible biomarkers in blood for crohn's disease: oxidative stress and micrornas-current evidences and further aspects to unravel","volume":"2016","author":"Moret-Tatay","year":"2016","journal-title":"Oxid Med Cell Longev."},{"key":"B203","doi-asserted-by":"publisher","first-page":"256","DOI":"10.9758\/cpn.2016.14.3.256","article-title":"Investigation of dysregulation of several micrornas in peripheral blood of schizophrenia patients","volume":"14","author":"Camkurt","year":"2016","journal-title":"Clin Psychopharmacol Neurosci."},{"key":"B204","doi-asserted-by":"publisher","first-page":"e717","DOI":"10.1038\/tp.2015.213","article-title":"Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue","volume":"6","author":"Lai","year":"2016","journal-title":"Transl Psychiatry"},{"key":"B205","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1176\/appi.ajp.2015.14030273","article-title":"Detection of circulating miRNA levels in schizophrenia","volume":"172","author":"Wei","year":"2015","journal-title":"Am J Psychiatry"},{"key":"B206","doi-asserted-by":"publisher","first-page":"9383","DOI":"10.1073\/pnas.87.23.9383","article-title":"series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism","volume":"87","author":"Morrow","year":"1990","journal-title":"Proc Nat Acad Sci."},{"key":"B207","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S0165-6147(02)02053-9","article-title":"Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications","volume":"23","author":"Cracowski","year":"2002","journal-title":"Trends Pharmacol Sci."},{"key":"B208","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1096\/fj.04-2330rev","article-title":"Isoprostanes: markers and mediators of oxidative stress","volume":"18","author":"Montuschi","year":"2004","journal-title":"The FASEB J."},{"key":"B209","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0920-9964(94)90084-1","article-title":"A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases","volume":"12","author":"Glen","year":"1994","journal-title":"Schizophr Res."},{"key":"B210","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.schres.2006.11.027","article-title":"Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications","volume":"91","author":"McNamara","year":"2007","journal-title":"Schizophr Res."},{"key":"B211","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0920-9964(99)00095-X","article-title":"Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients","volume":"42","author":"Yao","year":"2000","journal-title":"Schizophr Res."},{"key":"B212","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S0278-5846(03)00152-0","article-title":"On the relationship between methylnicotinate-induced skin flush and fatty acids levels in acute psychosis","volume":"27","author":"Maclean","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol."},{"key":"B213","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.schres.2010.03.025","article-title":"Niacin sensitivity and the arachidonic acid pathway in schizophrenia","volume":"122","author":"Messamore","year":"2010","journal-title":"Schizophr Res."},{"key":"B214","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0920-9964(97)00151-5","article-title":"The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia","volume":"30","author":"Horrobin","year":"1998","journal-title":"Schizophr Res."},{"key":"B215","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.pnpbp.2005.04.034","article-title":"Membrane phospholipid composition, alterations in neurotransmitter systems and schizophrenia","volume":"29","author":"du Bois","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol."},{"key":"B216","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0014-5793(00)01159-5","article-title":"Expression of fatty acid-CoA ligase 4 during development and in brain","volume":"467","author":"Cao","year":"2000","journal-title":"FEBS Lett."},{"key":"B217","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/ajmg.b.20156","article-title":"Association of a long-chain fatty acid-CoA ligase 4 gene polymorphism with depression and with enhanced niacin-induced dermal erythema","volume":"127","author":"Covault","year":"2004","journal-title":"Am J Med Genet B Neuropsychiatr Genet."},{"key":"B218","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.4049\/jimmunol.138.12.4353","article-title":"Arachidonic acid acts as an intracellular activator of NADPH-oxidase in Fc gamma receptor-mediated superoxide generation in macrophages","volume":"138","author":"Sakata","year":"1987","journal-title":"J Immunol."},{"key":"B219","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1006\/bbrc.1993.2039","article-title":"Combination of Arachidonic Acid and Guanosine 5\u2032-O-(3-Thiotriphosphate) Induces Translocation of rac p21s to Membrane and Activation of NADPH Oxidase in a Cell-Free System","volume":"195","author":"Sawai","year":"1993","journal-title":"Biochem Biophys Res Commun."},{"key":"B220","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1042\/bj2980585","article-title":"Activation of NADPH oxidase involves the dissociation of p21rac from its inhibitory GDP\/GTP exchange protein (rhoGDI) followed by its translocation to the plasma membrane","volume":"298","author":"Abo","year":"1994","journal-title":"Biochemical Journal."},{"key":"B221","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0092-8674(05)80019-4","article-title":"Selective activation of the JNK signaling cascadeand c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs","volume":"81","author":"Minden","year":"1995","journal-title":"Cell."},{"key":"B222","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.schres.2011.01.018","article-title":"The anti-inflammatory prostaglandin 15d-PGJ2 and its nuclear receptor PPARgamma are decreased in schizophrenia","volume":"128","author":"Mart\u00ednez-Gras","year":"2011","journal-title":"Schizophr Res."},{"key":"B223","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/BF00969006","article-title":"Oxidative mechanisms involved in kainate-induced cytotoxicity in cortical neurons","volume":"19","author":"Cheng","year":"1994","journal-title":"Neurochem Res."},{"key":"B224","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/1523-1747.ep12499963","article-title":"Identification of skin as a major site on prostaglandin D2 release following oral administration of niacin in humans","volume":"98","author":"Morrow","year":"1992","journal-title":"J Investigat Dermatol."},{"key":"B225","first-page":"13","article-title":"Inhibition of flush induced by nicotinic acid","volume":"10","author":"Aberg","year":"1973","journal-title":"IRCS (General Pharmacology)."},{"key":"B226","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0773.1977.tb02116.x","article-title":"Studies on the Mechanism of Flush Induced by Nicotinic Acid","volume":"41","author":"Andersson","year":"1977","journal-title":"Acta Pharmacol Toxicol."},{"key":"B227","doi-asserted-by":"publisher","first-page":"10989","DOI":"10.1073\/pnas.90.23.10989","article-title":"Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP","volume":"90","author":"D'Mello","year":"1993","journal-title":"Proc Nat Acad Sci."},{"key":"B228","doi-asserted-by":"publisher","first-page":"9869","DOI":"10.1074\/jbc.M210695200","article-title":"Molecular identification of high and low affinity receptors for nicotinic acid","volume":"278","author":"Wise","year":"2003","journal-title":"J Biol Chem."},{"key":"B229","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/sj.clpt.6100180","article-title":"Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1","volume":"81","author":"Lai","year":"2007","journal-title":"Clin Pharmacol Ther."},{"key":"B230","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1523\/JNEUROSCI.17-08-02746.1997","article-title":"Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage","volume":"17","author":"Nogawa","year":"1997","journal-title":"J Neurosci."},{"key":"B231","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/sj.bjp.0704261","article-title":"Effects of S-2474, a novel nonsteroidal anti-inflammatory drug, on amyloid \u03b2 protein-induced neuronal cell death","volume":"134","author":"Yagami","year":"2001","journal-title":"Br J Pharmacol."},{"key":"B232","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1046\/j.1471-4159.2003.01712.x","article-title":"Human group IIA secretory phospholipase A2 potentiates Ca2+ influx through L-type voltage-sensitive Ca2+ channels in cultured rat cortical neurons","volume":"85","author":"Yagami","year":"2003","journal-title":"J Neurochem."},{"key":"B233","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1471-4159.2004.02870.x","article-title":"Prostaglandin D2 mediates neuronal protection via the DP1 receptor","volume":"92","author":"Liang","year":"2005","journal-title":"J Neurochem."},{"key":"B234","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.brainres.2006.05.048","article-title":"Cytosolic prostaglandin E2 synthase (cPGES) expression is decreased in discrete cortical regions in psychiatric disease","volume":"1103","author":"Maida","year":"2006","journal-title":"Brain Res."},{"key":"B235","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/BF01255817","article-title":"Elevated plasma prostaglandin E2 levels in schizophrenia","volume":"77","author":"Kaiya","year":"1989","journal-title":"J Neural Transm."},{"key":"B236","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.2174\/138161208784480243","article-title":"COX-2 inhibition in schizophrenia and major depression","volume":"14","author":"Muller","year":"2008","journal-title":"Curr Pharm Des."},{"key":"B237","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0952-3278(98)90109-0","article-title":"Increased arachidonic acid induced platelet chemiluminescence indicates cyclooxygenase overactivity in schizophrenic subjects","volume":"58","author":"Das","year":"1998","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids."},{"key":"B238","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.2174\/138920112800784826","article-title":"Immunological treatment options for schizophrenia","volume":"13","author":"M\u00fcller","year":"2012","journal-title":"Curr Pharm Biotechnol."},{"key":"B239","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-6-18","article-title":"Subchronic infusion of the product of inflammation prostaglandin J2 models sporadic Parkinson's disease in mice","volume":"6","author":"Pierre","year":"2009","journal-title":"J Neuroinflammation."},{"key":"B240","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/S0006-2952(02)00844-4","article-title":"Inhibition of inducible prostaglandin E2 synthase by 15-deoxy-\u039412, 14-prostaglandin J2 and polyunsaturated fatty acids","volume":"63","author":"Quraishi","year":"2002","journal-title":"Biochem Pharmacol."},{"key":"B241","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ajp.2019.09.026","article-title":"Serum PGE2, 15d-PGJ, PPAR\u03b3 and CRP levels in patients with schizophrenia","volume":"46","author":"Y\u00fcksel","year":"2019","journal-title":"Asian J Psychiatr."},{"key":"B242","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/0092-8674(95)90194-9","article-title":"prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor \u03b3 and promotes adipocyte differentiation","volume":"83","author":"Kliewer","year":"1995","journal-title":"Cell."},{"key":"B243","doi-asserted-by":"publisher","first-page":"11713","DOI":"10.1016\/S0021-9258(17)44287-6","article-title":"Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro","volume":"258","author":"Fitzpatrick","year":"1983","journal-title":"J Biol Chem."},{"key":"B244","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0891-0618(00)00041-7","article-title":"Temporal, regional, and cell-specific changes of iNOS expression after intrastriatal microinjection of interferon gamma and bacterial lipopolysaccharide","volume":"18","author":"Heneka","year":"2000","journal-title":"J Chem Neuroanat."},{"key":"B245","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/j.1745-7254.2006.00359.x","article-title":"Dong Y-g, Li H-l. PPAR\u03b3 phosphorylation mediated by JNK MAPK: a potential role in macrophage-derived foam cell formation","volume":"27","author":"Yin","year":"2006","journal-title":"Acta Pharmacologica Sinica."},{"key":"B246","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/jnc.13101","article-title":"Regulation of peroxisome proliferator-activated receptors (PPAR) \u03b1 and -\u03b3 of rat brain astrocytes in the course of activation by toll-like receptor agonists","volume":"134","author":"Chistyakov","year":"2015","journal-title":"J Neurochem."},{"key":"B247","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1210\/endo.140.1.6457","article-title":"c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-\u03b31 and negatively regulates its transcriptional activity","volume":"140","author":"Camp","year":"1999","journal-title":"Endocrinology."},{"key":"B248","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fncel.2017.00064","article-title":"Adiponectin Regulates the polarization and function of microglia via PPAR-\u03b3 signaling under amyloid \u03b2 toxicity","volume":"11","author":"Song","year":"2017","journal-title":"Front Cellular Neurosci"},{"key":"B249","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1172\/JCI36806","article-title":"beta-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice","volume":"119","author":"Walters","year":"2009","journal-title":"J Clin Invest."},{"key":"B250","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fendo.2015.00167","article-title":"A broad G protein-coupled receptor internalization assay that combines SNAP-tag labeling, diffusion-enhanced resonance energy transfer, and a highly emissive terbium cryptate","volume":"6","author":"Levoye","year":"2015","journal-title":"Front Endocrinol"},{"key":"B251","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.nbd.2011.07.009","article-title":"Reduced expression of G protein-coupled receptor kinases in schizophrenia but not in schizoaffective disorder","volume":"44","author":"Bychkov","year":"2011","journal-title":"Neurobiol Dis."},{"key":"B252","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/S0140-6736(77)92228-0","article-title":"Schizophrenia as a prostaglandin deficiency disease","volume":"1","author":"Horrobin","year":"1977","journal-title":"Lancet."},{"key":"B253","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/sj.bjp.0703573","article-title":"Investigation into the involvement of phospholipases A2 and MAP kinases in modulation of AA release and cell growth in A549 cells","volume":"131","author":"Choudhury","year":"2000","journal-title":"Br J Pharmacol."},{"key":"B254","doi-asserted-by":"publisher","first-page":"5268","DOI":"10.1016\/S0021-9258(19)67782-3","article-title":"The Ca2(+)-sensitive cytosolic phospholipase A2 is a 100-kDa protein in human monoblast U937 cells","volume":"266","author":"Kramer","year":"1991","journal-title":"J Biol Chem."},{"key":"B255","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.bbalip.2006.07.011","article-title":"The phospholipase A2 superfamily and its group numbering system","volume":"1761","author":"Schaloske","year":"2006","journal-title":"Biochim Biophys Acta."},{"key":"B256","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.plefa.2009.05.024","article-title":"Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection","volume":"81","author":"Bazan","year":"2009","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids."},{"key":"B257","doi-asserted-by":"publisher","first-page":"532","DOI":"10.2174\/092986712798918851","article-title":"n-3 fatty acid-derived lipid mediators in the brain: new weapons against oxidative stress and inflammation","volume":"19","author":"A Farooqui","year":"2012","journal-title":"Current Med Chem"},{"key":"B258","doi-asserted-by":"publisher","first-page":"29317","DOI":"10.1074\/jbc.272.46.29317","article-title":"Antisense inhibition of group VI Ca2+-independent phospholipase A2 blocks phospholipid fatty acid remodeling in murine P388D1 macrophages","volume":"272","author":"Balsinde","year":"1997","journal-title":"J Biol Chem."},{"key":"B259","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0165-3806(94)90012-4","article-title":"Blockade of long-term depression in neonatal hippocampal slices by a phospholipase A2 inhibitor","volume":"78","author":"Fitzpatrick","year":"1994","journal-title":"Dev Brain Res."},{"key":"B260","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1155\/2012\/569149","article-title":"Maintenance of synaptic stability requires calcium-independent phospholipase A2 activity","volume":"2012","author":"Allyson","year":"2012","journal-title":"Neural Plasticity"},{"key":"B261","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1385\/1-59259-879-X:353","article-title":"Methods for the detection of altered beta-adrenergic receptor signaling pathways in hypertrophied hearts","volume":"112","author":"Wolf","year":"2005","journal-title":"Methods Mol Med."},{"key":"B262","doi-asserted-by":"publisher","first-page":"20713","DOI":"10.1016\/S0021-9258(19)36837-1","article-title":"Arachidonic acid release from aortic smooth muscle cells induced by [Arg8]vasopressin is largely mediated by calcium-independent phospholipase A2","volume":"268","author":"Lehman","year":"1993","journal-title":"J Biol Chem."},{"key":"B263","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1074\/jbc.274.5.3103","article-title":"Functional coupling between various phospholipase A2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways","volume":"274","author":"Murakami","year":"1999","journal-title":"J Biol Chem."},{"key":"B264","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1126\/science.7824938","article-title":"Transcription factor ATF2 regulation by the JNK signal transduction pathway","volume":"267","author":"Gupta","year":"1995","journal-title":"Science."},{"key":"B265","doi-asserted-by":"publisher","first-page":"6691","DOI":"10.1074\/jbc.M508314200","article-title":"Group V secretory phospholipase A2 translocates to the phagosome after zymosan stimulation of mouse peritoneal macrophages and regulates phagocytosis","volume":"281","author":"Balestrieri","year":"2006","journal-title":"J Biol Chem."},{"key":"B266","doi-asserted-by":"publisher","first-page":"13057","DOI":"10.1016\/S0021-9258(17)36794-7","article-title":"Diversity of group types, regulation, and function of phospholipase A2","volume":"269","author":"Dennis","year":"1994","journal-title":"J Biol Chem."},{"key":"B267","doi-asserted-by":"publisher","first-page":"8823","DOI":"10.1074\/jbc.274.13.8823","article-title":"Molecular cloning of two new human paralogs of 85-kDa cytosolic phospholipase A2","volume":"274","author":"Pickard","year":"1999","journal-title":"J Biol Chem."},{"key":"B268","doi-asserted-by":"publisher","first-page":"21926","DOI":"10.1074\/jbc.273.34.21926","article-title":"novel calcium-independent phospholipase A2, cPLA2-\u03b3, that is prenylated and contains homology to cPLA2","volume":"273","author":"Underwood","year":"1998","journal-title":"J Biol Chem."},{"key":"B269","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/0888-7543(95)80093-2","article-title":"Cytosolic phospholipase A2 gene in human and rat: chromosomal localization and polymorphic markers","volume":"26","author":"Tay","year":"1995","journal-title":"Genomics."},{"key":"B270","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0920-9964(96)00031-X","article-title":"Genetic variant near cytosolic phospholipase A2 associated with schizophrenia","volume":"21","author":"Hudson","year":"1996","journal-title":"Schizophr Res."},{"key":"B271","article-title":"Membrane abnormalities in schizophrenia as revealed by tyrosine transport","volume-title":"In: Phospholid Spectrum Disorder in Psychiatry.","author":"Bjerkenstedt","year":"1999"},{"key":"B272","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/00041444-199800830-00010","article-title":"Association of the Ban I dimorphic site at the human cytosolic phospholipase A2 gene with schizophrenia","volume":"8","author":"Peet","year":"1998","journal-title":"Psychiatr Genet."},{"key":"B273","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s00406-007-0736-0","article-title":"Association between BanI genotype and increased phospholipase A2 activity in schizophrenia","volume":"257","author":"Barbosa","year":"2007","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"B274","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/sj.mp.4000445","article-title":"Is the cPLA2 gene associated with schizophrenia","volume":"3","author":"Wei","year":"1998","journal-title":"Mol Psychiatry."},{"key":"B275","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.pnpbp.2004.05.009","article-title":"BanI polymorphism of the cytosolic phospholipase A2 gene may confer susceptibility to the development of schizophrenia","volume":"28","author":"Pae","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol."},{"key":"B276","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/00041444-199723000-00004","article-title":"Lack of association between schizophrenia and a polymorphism close to the cytosolic phospholipase A2 gene","volume":"7","author":"Price","year":"1997","journal-title":"Psychiatr Genet."},{"key":"B277","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/00041444-200112000-00005","article-title":"Association studies of cytosolic phospholipase A2 polymorphisms and schizophrenia among two independent family-based samples","volume":"11","author":"Chowdari","year":"2001","journal-title":"Psychiatr Genet."},{"key":"B278","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/ajmg.1262","article-title":"Lack of association between schizophrenia and the phospholipase-A2 genes cPLA2 and sPLA2","volume":"105","author":"Frieboes","year":"2001","journal-title":"Am J Med Genet."},{"key":"B279","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/gb-2004-5-9-241","article-title":"The cyclooxygenases","volume":"5","author":"Chandrasekharan","year":"2004","journal-title":"Genome Biol."},{"key":"B280","first-page":"59","article-title":"Transcriptional regulation of cyclo-oxygenase expression: three pillars of control","volume":"16","author":"Ramsay","year":"2003","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B281","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/384644a0","article-title":"Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents","volume":"384","author":"Kurumbail","year":"1996","journal-title":"Nature."},{"key":"B282","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-94-011-4872-6_1","article-title":"Mechanism of action of anti-inflammatory drugs: an overview.","volume-title":"Selective COX-2 Inhibitors: Pharmacology, Clinical Effects and Therapeutic Potential","author":"Vane","year":"1998"},{"key":"B283","doi-asserted-by":"publisher","first-page":"5957","DOI":"10.1002\/j.1460-2075.1995.tb00284.x","article-title":"Induction of c-fos expression through JNK-mediated TCF\/Elk-1 phosphorylation","volume":"14","author":"Cavigelli","year":"1995","journal-title":"EMBO J."},{"key":"B284","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0005-2760(97)00129-X","article-title":"Different substrate utilization between prostaglandin endoperoxide H synthase-1 and-2 in NIH3T3 fibroblasts","volume":"1389","author":"Shitashige","year":"1998","journal-title":"Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism."},{"key":"B285","doi-asserted-by":"publisher","first-page":"15473","DOI":"10.1016\/S0021-9258(17)40703-4","article-title":"Ligand-induced prostaglandin synthesis requires expression of the TIS10\/PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages","volume":"269","author":"Reddy","year":"1994","journal-title":"J Biol Chem."},{"key":"B286","doi-asserted-by":"publisher","first-page":"24019","DOI":"10.1074\/jbc.270.41.24019","article-title":"Comparison of hydroperoxide initiator requirements for the cyclooxygenase activities of prostaglandin H synthase-1 and\u22122","volume":"270","author":"Kulmacz","year":"1995","journal-title":"J Biol Chem."},{"key":"B287","doi-asserted-by":"publisher","first-page":"22663","DOI":"10.1074\/jbc.271.37.22663","article-title":"The highly stereoselective oxidation of polyunsaturated fatty acids by cytochrome P450BM-3","volume":"271","author":"Capdevila","year":"1996","journal-title":"J Biol Chem."},{"key":"B288","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0920-9964(02)00311-0","article-title":"The niacin skin flush abnormality in schizophrenia: a quantitative dose\u2013response study","volume":"62","author":"Messamore","year":"2003","journal-title":"Schizophr Res."},{"key":"B289","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1042\/bj3100083","article-title":"Glutamate stably enhances the activity of two cytosolic forms of phospholipase A2 in brain cortical cultures","volume":"310","author":"Kim","year":"1995","journal-title":"Biochem J."},{"key":"B290","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0006-8993(99)01123-3","article-title":"Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia","volume":"821","author":"Ross","year":"1999","journal-title":"Brain Res."},{"key":"B291","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.psychres.2019.01.095","article-title":"An investigation of calcium-independent phospholipase A2 (iPLA2) and cytosolic phospholipase A2 (cPLA2) in schizophrenia","volume":"273","author":"Xu","year":"2019","journal-title":"Psychiatry Res."},{"key":"B292","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/schbul\/19.1.35","article-title":"31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia","volume":"19","author":"Pettegrew","year":"1993","journal-title":"Schizophr Bull."},{"key":"B293","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0920-9964(02)00281-5","article-title":"Increased phospholipase A2 activity in schizophrenia with absent response to niacin","volume":"61","author":"Tavares","year":"2003","journal-title":"Schizophr Res."},{"key":"B294","first-page":"1419","article-title":"Deficiency of vitamin E and selenium enhances calcium-independent phospholipase A2 activity in rat lung and liver","volume":"125","author":"Kuo","year":"1995","journal-title":"J Nutr."},{"key":"B295","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.psychres.2013.08.035","article-title":"Oxidative stress in schizophrenia patients treated with long-acting haloperidol decanoate","volume":"210","author":"Bo\u0161kovi\u0107","year":"2013","journal-title":"Psychiatry Res."},{"key":"B296","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/sj.mp.4001511","article-title":"Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress","volume":"9","author":"Prabakaran","year":"2004","journal-title":"Mol Psychiatry."},{"key":"B297","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1194\/jlr.M700419-JLR200","article-title":"cPLA2 phosphorylation at serine-515 and serine-505 is required for arachidonic acid release in vascular smooth muscle cells","volume":"49","author":"Pavicevic","year":"2008","journal-title":"J Lipid Res."},{"key":"B298","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.1074\/jbc.273.8.4449","article-title":"Identification of the phosphorylation sites of cytosolic phospholipase A2 in agonist-stimulated human platelets and HeLa cells","volume":"273","author":"B\u00f6rsch-Haubold","year":"1998","journal-title":"J Biol Chem."},{"key":"B299","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/jlb.65.3.330","article-title":"Regulation of arachidonic acid release and cytosolic phospholipase A2 activation","volume":"65","author":"Gij\u00f3n","year":"1999","journal-title":"J Leukoc Biol."},{"key":"B300","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/sj.mp.4001819","article-title":"The role of phospholipases A2 in schizophrenia","volume":"11","author":"Law","year":"2006","journal-title":"Mol Psychiatry."},{"key":"B301","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1681\/ASN.V102404","article-title":"The 85-kD Cytosolic Phospholipase A Knockout Mouse. A New Tool for Physiology and Cell Biology","volume":"10","author":"Bonventre","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"B302","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1006\/bbrc.1999.1964","article-title":"Phosphorylation of cytosolic group IV phospholipase A2 is necessary but not sufficient for arachidonic acid release in P388D1 macrophages","volume":"267","author":"Balboa","year":"2000","journal-title":"Biochem Biophys Res Commun."},{"key":"B303","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1074\/jbc.274.1.522","article-title":"Proinflammatory macrophage-activating properties of the novel phospholipid diacylglycerol pyrophosphate","volume":"274","author":"Balboa","year":"1999","journal-title":"J Biol Chem"},{"key":"B304","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.4049\/jimmunol.0804003","article-title":"Coordinate regulation of TLR-mediated arachidonic acid mobilization in macrophages by group IVA and group V phospholipase A2s","volume":"182","author":"Ruip\u00e9rez","year":"2009","journal-title":"J Immunol."},{"key":"B305","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.4049\/jimmunol.0901530","article-title":"Requirement of JNK-Mediated Phosphorylation for Translocation of Group IVA Phospholipase A to Phagosomes in Human Macrophages","volume":"183","author":"Casas","year":"2009","journal-title":"J Immunol."},{"key":"B306","doi-asserted-by":"publisher","first-page":"7438","DOI":"10.1073\/pnas.88.16.7438","article-title":"Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system","volume":"88","author":"Sedgwick","year":"1991","journal-title":"Proc Natl Acad Sci."},{"key":"B307","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1073\/pnas.94.6.2569","article-title":"Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method","volume":"94","author":"Breier","year":"1997","journal-title":"Proc Nat Acad Sci."},{"key":"B308","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1046\/j.1471-4159.1995.64062765.x","article-title":"Dopamine D2 Receptors Potentiate Arachidonate Release via Activation of Cytosolic, Arachidonate-Specific Phospholipase A2","volume":"64","author":"Vial","year":"1995","journal-title":"J Neurochem."},{"key":"B309","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mce.2008.01.016","article-title":"Prostaglandin E2 and F2\u03b1 activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element","volume":"285","author":"Sales","year":"2008","journal-title":"Mol Cell Endocrinol."},{"key":"B310","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/j.1471-4159.2006.03926.x","article-title":"Cyclooxygenase-1 and-2 enzymes differentially regulate the brain upstream NF-\u03baB pathway and downstream enzymes involved in prostaglandin biosynthesis","volume":"98","author":"Choi","year":"2006","journal-title":"J Neurochem."},{"key":"B311","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.molbrainres.2005.05.008","article-title":"Down-regulation of brain nuclear factor-kappa B pathway in the cyclooxygenase-2 knockout mouse","volume":"139","author":"Rao","year":"2005","journal-title":"Mol Brain Res."},{"key":"B312","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1074\/jbc.M209286200","article-title":"Up-regulation of p300 binding and p50 acetylation in tumor necrosis factor-alpha-induced cyclooxygenase-2 promoter activation","volume":"278","author":"Deng","year":"2003","journal-title":"J Biol Chem."},{"key":"B313","doi-asserted-by":"publisher","first-page":"F97","DOI":"10.1152\/ajprenal.1992.263.1.F97","article-title":"Regulation of mesangial cell cyclooxygenase synthesis by cytokines and glucocorticoids","volume":"263","author":"Coyne","year":"1992","journal-title":"Am J Physiol."},{"key":"B314","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1517\/13543784.8.10.1521","article-title":"COX-2 and Alzheimer's disease: potential roles in inflammation and neurodegeneration","volume":"8","author":"O'Banion","year":"1999","journal-title":"Expert Opin Investig Drugs."},{"key":"B315","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/sj.npp.1300756","article-title":"Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics","volume":"30","author":"Zhang","year":"2005","journal-title":"Neuropsychopharmacology."},{"key":"B316","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/schbul\/sbv028","article-title":"Cortisol and inflammatory biomarkers predict poor treatment response in first episode psychosis","volume":"41","author":"Mondelli","year":"2015","journal-title":"Schizophr Bull."},{"key":"B317","doi-asserted-by":"publisher","first-page":"414","DOI":"10.4088\/JCP.10r06823","article-title":"Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis","volume":"73","author":"Sommer","year":"2011","journal-title":"J Clinical Psychiat."},{"key":"B318","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/schbul\/sbt070","article-title":"Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials","volume":"39","author":"Nitta","year":"2013","journal-title":"Schizophr Bull."},{"key":"B319","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1176\/appi.ajp.159.6.1029","article-title":"Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia","volume":"159","author":"M\u00fcller","year":"2002","journal-title":"Am J Psychiatry."},{"key":"B320","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00406-004-0478-1","article-title":"COX-2 inhibition as a treatment approach in schizophrenia: Immunological considerations and clinical effects of celecoxib add-on therapy","volume":"254","author":"M\u00fcller","year":"2004","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"B321","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.schres.2010.04.015","article-title":"Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment","volume":"121","author":"M\u00fcller","year":"2010","journal-title":"Schizophr Res."},{"key":"B322","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.pharmthera.2004.06.003","article-title":"Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation","volume":"103","author":"Hata","year":"2004","journal-title":"Pharmacol Ther."},{"key":"B323","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0163-7827(03)00037-7","article-title":"Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway","volume":"43","author":"Murakami","year":"2004","journal-title":"Prog Lipid Res."},{"key":"B324","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.neuroscience.2006.05.001","article-title":"Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern","volume":"141","author":"Melnikova","year":"2006","journal-title":"Neuroscience."},{"key":"B325","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1046\/j.1471-4159.2000.740443.x","article-title":"Roles of nuclear factor \u03baB in neuronal survival and plasticity","volume":"74","author":"Mattson","year":"2000","journal-title":"J Neurochem."},{"key":"B326","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/35102591","article-title":"A subset of NSAIDs lower amyloidogenic A\u03b242 independently of cyclooxygenase activity","volume":"414","author":"Weggen","year":"2001","journal-title":"Nature."},{"key":"B327","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1046\/j.1471-4159.2002.01195.x","article-title":"Selective inhibition of A\u03b242 production by NSAID R-enantiomers","volume":"83","author":"Morihara","year":"2002","journal-title":"J Neurochem."},{"key":"B328","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1096\/fj.00-0716fje","article-title":"Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-\u03baB","volume":"15","author":"Niederberger","year":"2001","journal-title":"The FASEB Journal."},{"key":"B329","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1096\/fj.01-0390rev","article-title":"Cyclooxygenase-independent actions of cyclooxygenase inhibitors","volume":"15","author":"Tegeder","year":"2001","journal-title":"The FASEB Journal."},{"key":"B330","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S1471-4906(01)02154-8","article-title":"Prostaglandins as modulators of immunity","volume":"23","author":"Harris","year":"2002","journal-title":"Trends Immunol."},{"key":"B331","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.bbrc.2005.10.051","article-title":"Prostaglandin E2 induces cyclooxygenase-2 expression in human non-pigmented ciliary epithelial cells through activation of p38 and p42\/44 mitogen-activated protein kinases","volume":"338","author":"R\u00f6sch","year":"2005","journal-title":"Biochem Biophys Res Commun."},{"key":"B332","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.mcn.2007.12.019","article-title":"COX-2 oxidative metabolism of endocannabinoids augments hippocampal synaptic plasticity","volume":"37","author":"Yang","year":"2008","journal-title":"Mol Cell Neurosci."},{"key":"B333","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.intimp.2006.01.009","article-title":"JNK inhibitor SP600125 reduces COX-2 expression by attenuating mRNA in activated murine J774 macrophages","volume":"6","author":"Nieminen","year":"2006","journal-title":"Int Immunopharmacol."},{"key":"B334","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1155\/MI.2005.249","article-title":"Inhibitors of mitogen-activated protein kinases downregulate COX-2 expression in human chondrocytes","volume":"2005","author":"Nieminen","year":"2005","journal-title":"Mediators Inflamm."},{"key":"B335","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3389\/fimmu.2019.00536","article-title":"Defective Induction of COX-2 Expression by Psoriatic Fibroblasts Promotes Pro-inflammatory Activation of Macrophages","volume":"10","author":"Arasa","year":"2019","journal-title":"Front Immunol."},{"key":"B336","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.4049\/jimmunol.171.6.3047","article-title":"Candida albicans induces selectively transcriptional activation of cyclooxygenase-2 in HeLa cells: pivotal roles of Toll-like receptors, p38 mitogen-activated protein kinase, and NF-kappa B","volume":"171","author":"Deva","year":"2003","journal-title":"J Immunol."},{"key":"B337","first-page":"124","article-title":"Roles Of Cyclooxygenase-2 In Microglial Activation And Dopaminergic Cell Death","volume-title":"In: College of Medicine.","author":"Vijitruth","year":"2006"},{"key":"B338","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1177\/0269881112444941","article-title":"Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment","volume":"26","author":"Chaudhry","year":"2012","journal-title":"Journal of psychopharmacology."},{"key":"B339","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/1521654031000153049","article-title":"Role for NOX NADPH Oxidases in Alzheimer's Disease and Other Types of Dementia?","volume":"55","author":"Zekry","year":"2003","journal-title":"IUBMB Life."},{"key":"B340","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.gpb.2015.02.001","article-title":"Exosome and exosomal microRNA: trafficking, sorting, and function","volume":"13","author":"Zhang","year":"2015","journal-title":"Genom Proteom Bioinform."},{"key":"B341","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/978-1-4939-7601-0_6","article-title":"Exosomal microRNAs as potential biomarkers in neuropsychiatric disorders","author":"Fries","year":"2018","journal-title":"MicroRNA Protocols"},{"key":"B342","doi-asserted-by":"publisher","first-page":"7321","DOI":"10.1038\/ncomms8321","article-title":"Exosomedelivered microRNAs modulate the inflammatory response to endotoxin","volume":"6","author":"Alexander","year":"2015","journal-title":"Nat Commun."},{"key":"B343","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/schbul\/sbaa166","article-title":"Metabolomic Identification of Exosome-Derived Biomarkers for Schizophrenia: A Large Multicenter Study","volume":"47","author":"Du","year":"2020","journal-title":"Schizophr Bull."},{"key":"B344","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41588-018-0059-2","article-title":"Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection","volume":"50","author":"Pardi\u00f1as","year":"2018","journal-title":"Nat Genet."},{"key":"B345","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41588-018-0081-4","article-title":"Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types","volume":"50","author":"Finucane","year":"2018","journal-title":"Nat Genet."},{"key":"B346","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/s41588-018-0129-5","article-title":"Genetic identification of brain cell types underlying schizophrenia","volume":"50","author":"Skene","year":"2018","journal-title":"Nat Genet."},{"key":"B347","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/s41593-018-0197-y","article-title":"Developmental and genetic regulation of the human cortex transcriptome illuminate schizophrenia pathogenesis","volume":"21","author":"Jaffe","year":"2018","journal-title":"Nat Neurosci."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.771144\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T21:24:36Z","timestamp":1673904276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.771144\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,30]]},"references-count":347,"alternative-id":["10.3389\/fpsyt.2021.771144"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2021.771144","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,30]]},"article-number":"771144"}}